alexa Ten-year trends in quality of care and spending for depression: 1996 through 2005.
Psychiatry

Psychiatry

Journal of Neuropsychopharmacology & Mental Health

Author(s): Fullerton CA, Busch AB, Normand SL, McGuire TG, Epstein AM

Abstract Share this page

Abstract CONTEXT: During the past decade, the introduction of generic versions of newer antidepressants and the release of Food and Drug Administration warnings regarding suicidality in children, adolescents, and young adults may have had an effect on cost and quality of depression treatment. OBJECTIVES: To examine longitudinal trends in health service utilization, spending, and quality of care for depression. DESIGN: Observational trend study. SETTING: Florida Medicaid enrollees, between July 1, 1996, and June 30, 2006. Patients Annual cohorts aged 18 to 64 years diagnosed as having depression. MAIN OUTCOME MEASURES: Mental health care spending (adjusted for inflation and case mix), as well as its components, including inpatient, outpatient, and medication expenditures. Quality-of-care measures included medication adherence, psychotherapy, and follow-up visits. RESULTS: Mental health care spending increased from a mean of $2802 per enrollee to $3610 during this period (29\% increase). This increase occurred despite a mean decrease in inpatient spending from $641 per enrollee to $373 and was driven primarily by an increase in pharmacotherapy spending (up 110\%), the bulk of which was due to spending on antipsychotics (949\% increase). The percentage of enrollees with depression who were hospitalized decreased from 9.1\% to 5.1\%, and the percentage who received psychotherapy decreased from 56.6\% to 37.5\%. Antidepressant use increased from 80.6\% to 86.8\%, anxiety medication use was unchanged at 62.7\% and 64.4\%, and antipsychotic use increased from 25.9\% to 41.9\%. Changes in quality of care were mixed, with antidepressant use improving slightly, psychotherapy utilization fluctuating, and follow-up visits decreasing. CONCLUSIONS: During a 10-year period, spending for Medicaid enrollees with depression increased substantially, with minimal improvements in quality of care. Antipsychotic use contributed significantly to the increase in spending, while contributing little to traditional measures of quality of care.
This article was published in Arch Gen Psychiatry and referenced in Journal of Neuropsychopharmacology & Mental Health

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords